| 9776992 |
1-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamide compounds, formulations containing those compounds, and their use as AICARFT inhibitors in the treatment of cancers |
Harold Burns Brooks, Robert Dally, Timothy Barrett Durham, Kevin Robert Fales, Kwame Frimpong +6 more |
2017-10-03 |
$235,090,000 |
| 8765796 |
Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide |
Robert Jason Herr, Louis Nickolaus Jungheim, John McNeill McGill, Muralikrishna Valluri |
2014-07-01 |
|
| 8552039 |
Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide |
Robert Jason Herr, Louis Nickolaus Jungheim, John McNeil McGill, Muralikrishna Valluri |
2013-10-08 |
|
| 8546581 |
Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (Glp)-1 compound or a melanocortin-4 receptor (Mc4) agonist peptide |
Louis Nickolaus Jungheim, John McNeill McGill, Robert Jason Herr, Muralikrishna Valluri |
2013-10-01 |
|
| 7947841 |
Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide |
Louis Nickolaus Jungheim, John McNeill McGill, Robert Jason Herr, Valluri Muralikrishna |
2011-05-24 |
|
| 7662771 |
Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide |
Robert Jason Herr, Louis Nickolaus Jungheim, John McNeill McGill, Muralikrishna Valluri |
2010-02-16 |
|
| 7125840 |
Substituted dipeptides as growth hormone secretagogues |
Jeffrey A. Dodge, Britta Evers, Louis Nickolaus Jungheim, Brian S. Muehl, Gerd Ruehter |
2006-10-24 |
$98,191,000 |
| 7101891 |
Compounds and pharmaceutical compositions for inhibiting MRP1 |
Jeffrey Daniel Cohen, Louis Nickolaus Jungheim, Brian S. Muehl |
2006-09-05 |
$72,797,000 |
| 7037921 |
Compounds and methods for inhibiting MRP1 |
Rosanne Bonjouklian, Louis Nickolaus Jungheim |
2006-05-02 |
$66,388,000 |
| 6992097 |
Growth hormone secretagogues |
Kenneth Lee Hauser, Jeffrey A. Dodge, Mark L. Heiman, Scott Alan Jones, Charles A. Alt +16 more |
2006-01-31 |
$137,113,000 |
| 6743794 |
Methods and compounds for inhibiting MRP1 |
Rosanne Bonjouklian, Jeffrey Daniel Cohen, Joseph Michael Gruber, Douglas Webb Johnson, Louis Nickolaus Jungheim +14 more |
2004-06-01 |
$118,923,000 |
| 6686372 |
Selective &bgr;3 adrenergic agonists |
Thomas Alan Crowell, Deborah A. Evrard, Charles D. Jones, Brian S. Muehl, Christopher J. Rito +2 more |
2004-02-03 |
$162,745,000 |
| 6639076 |
Growth hormone secretagogues |
Kenneth Lee Hauser, Jeffrey A. Dodge, Mark L. Heiman, Scott Alan Jones, Charles A. Alt +11 more |
2003-10-28 |
$145,966,000 |
| 6440958 |
Acrylic and propionic acid compounds, intermediates, processes, compositions, and methods |
Charles D. Jones, Alan David Palkowitz |
2002-08-27 |
$211,063,000 |
| 6413991 |
Selective &bgr;3 adrenergic agonists |
Thomas Alan Crowell, Deborah A. Evrard, Charles D. Jones, Brian S. Muehl, Christopher J. Rito +2 more |
2002-07-02 |
$313,924,000 |
| 6350884 |
Acrylic and propionic acid compounds, intermediates, processes, compositions, and method |
Charles D. Jones, Alan David Palkowitz |
2002-02-26 |
$168,169,000 |
| 6265575 |
Antithrombotic diamines |
Kenneth Lee Hauser, Alan David Palkowitz |
2001-07-24 |
$242,428,000 |
| 6258826 |
Pharmaceutical formulations and applications thereof for the treatment of estrogen deprivation syndrome |
George J. Cullinan, Brian S. Muehl |
2001-07-10 |
$472,227,000 |
| 6140352 |
Carbazolyl-substituted ethanolamines as selective .beta.-.sub.3 agonists |
Thomas Alan Crowell, Deborah A. Evrard, Charles D. Jones, Brian S. Muehl, Christopher J. Rito +2 more |
2000-10-31 |
$630,376,000 |
| 6087378 |
Pharmaceutical formulations and applications thereof for the treatment of estrogen deprivation syndrome |
George J. Cullinan, Brian S. Muehl |
2000-07-11 |
$224,711,000 |
| 6075151 |
Benzothiophene compounds, intermediates, processes, compositions, and methods |
Kenneth Lee Hauser, Alan David Palkowitz |
2000-06-13 |
$150,326,000 |
| 5986109 |
Benzothiophene compounds, intermediates, compositions, and methods |
Alan David Palkowitz |
1999-11-16 |
$111,097,000 |
| 5981765 |
Benzothiophene compounds, intermediates, compositions, and methods |
Alan David Palkowitz |
1999-11-09 |
$103,079,000 |
| 5969142 |
Benzothiophene compounds, intermediates, compositions and methods |
Alan David Palkowitz |
1999-10-19 |
$195,723,000 |
| 5856339 |
Benzothiophene compounds, intermediates, compositions, and methods |
Alan David Palkowitz |
1999-01-05 |
$208,307,000 |
